West Pharmaceutical (WST) announced that the company has reached a definitive agreement to sell all manufacturing and supply rights for SmartDose 3.5mL On-Body Delivery System and associated facilities to AbbVie (ABBV) for total consideration of $112.5M at close, subject to working capital and other adjustments. The definitive agreement, which is subject to certain closing conditions, is expected to close in mid-2026.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WST: